Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels
Ceramides are a type of sphingolipid (SL) that have been shown to play a role in several metabolic disorders. Here, the authors investigate the effect of SL-production by gut Bacteroides on host SL homeostasis and show that microbiome-derived SLs enter host circulation and alter ceramide production.
Main Authors: | Elizabeth L. Johnson, Stacey L. Heaver, Jillian L. Waters, Benjamin I. Kim, Alexis Bretin, Andrew L. Goodman, Andrew T. Gewirtz, Tilla S. Worgall, Ruth E. Ley |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-16274-w |
Similar Items
-
The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health
by: Jillian L. Waters, et al.
Published: (2019-10-01) -
Apoptotic Sphingolipid Ceramide in Cancer Therapy
by: Wei-Ching Huang, et al.
Published: (2011-01-01) -
Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling
by: Hiroko Hamai, et al.
Published: (2009-06-01) -
Sphingolipid and Ceramide Homeostasis: Potential Therapeutic Targets
by: Simon A. Young, et al.
Published: (2012-01-01) -
Structural determinants of sphingolipid recognition by commercially available anti-ceramide antibodies
by: L.Ashley Cowart, et al.
Published: (2002-12-01)